Estándar de tratamiento en primera línea de cáncer de páncreas metastásico: ¿ABRAXANE-GEMCITABINA o FOLFIRINOX? - page 1

ESTÁNDAR DE TRATAMIENTO EN PRIMERA LÍNEA

DE CÁNCER DE PÁNCREAS METASTÁSICO:

¿ABRAXANE-GEMCITABINA O FOLFIRINOX?

Andrés J. Muñoz Martín MD PhD

Servicio de Oncología Médica

Hospital General Universitario Gregorio Marañón

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1 2,3,4,5,6,7,8,9,10,11,...22